http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010222269-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_962adbf7d50e742218f3d536a63df612
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34
filingDate 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df825b70ebc17b42c23b63df5fd346af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7506798965d57702f529a6a07600ec60
publicationDate 2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2010222269-A
titleOfInvention Transdermal patch
abstract [PROBLEMS] To provide a transdermal patch which is excellent in rapid action of a drug and excellent in durability of the drug. A transdermal absorption patch 1a has a support substrate 10a, and a first drug-containing portion 11a and a second drug-containing portion 12a that are formed on the support substrate 10a and contain a drug. is doing. The first drug-containing portion 11a has a faster rate of releasing the drug to the skin than the second drug-containing portion 12a. The second drug-containing part 12a is installed so as to surround the first drug-containing part 11a. The first drug-containing portion 11a contains a transdermal absorption enhancer that promotes absorption of the drug into the skin. Between the first drug-containing portion 11a and the second drug-containing portion 12a, a gap 13a is provided as a blocking means for blocking the migration of the drug. [Selection] Figure 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012201612-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012201613-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012193137-A
priorityDate 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007031427-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61267510-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006525315-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415713226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3332

Total number of triples: 39.